Snack Sales Are Dropping: Is Weight Loss Medication to Blame?

In recent years, a noticeable shift has occurred in the snack food industry, with declining sales being reported by major companies. At the same time, weight loss medications such as Ozempic, Mounjaro, and Wegovy have surged. These drugs, known for their appetite-suppressing effects, have raised questions about whether their increasing popularity is contributing to the drop in snack sales. Let’s dive into the potential link between weight loss medications and changes in consumer snacking habits.

Weight Loss Medications & Appetite Suppression

Weight loss medications like Ozempic, Wegovy, and Mounjaro are designed to help individuals manage their weight by suppressing appetite. These drugs, particularly GLP-1 receptor agonists like Semaglutide (used in both Ozempic and Wegovy), work by mimicking a hormone that targets areas of the brain responsible for regulating hunger. As a result, users of these medications tend to experience:

• Reduced Hunger: Many individuals report feeling less hungry throughout the day, reducing their overall calorie intake.
• Decreased Cravings: In addition to curbing hunger, these medications help reduce cravings for high-calorie, sugary, and processed foods, which often include popular snack items.
• Improved Satiety: People using these medications tend to feel fuller for longer after eating smaller portions, which means they’re less likely to reach for snacks between meals.

With such profound effects on appetite and eating behavior, it’s no surprise that the rise in the use of these medications may be influencing snack consumption trends.

From our partner

Do you still have gout symptoms even though you're taking medication? You’re not alone. The Kadence study is a clinical research study for adults with uncontrolled gout. Learn More

Statistical Data on Snack Sales & Medication Use

In the last few years, snack sales have taken a dip, particularly in the U.S., where weight loss medications have significantly increased. According to market research, snack food sales dropped by approximately five percent in 2023, a decline that continues into 2024. At the same time, prescriptions for weight loss medications have surged, with an estimated 15 percent increase in 2023 alone.

A study from the Food Industry Association revealed that frequent snackers—those who eat multiple snacks per day—reported cutting back on their snacking habits in the last year. Many of these individuals attributed the decrease in snacking to changes in their appetite and weight loss efforts, with a growing number citing the use of weight loss medications as a factor.

The correlation between the rise of these appetite-suppressing drugs and the decline in snack sales suggests that as more people turn to medication for weight management, their purchasing habits—particularly for high-calorie, low-nutritional-value snacks—may be shifting.

From our partner

People 16+ years old struggling with lupus: Find out if the PHOENYCS FLY Study may be for you. Study-related care provided at no cost.

Industry Response to Decreasing Snack Sales

Snack food manufacturers and retailers are beginning to take notice of these changing consumer habits. In response to declining sales, several companies are adjusting their strategies to align with the new health-conscious trends:

• Healthier Snack Options: Companies are increasingly introducing snacks with lower calories, higher protein, and better nutritional profiles. The demand for plant-based, low-carb, and high-fiber snacks is rising as consumers, especially those on weight loss medications, prioritize healthier alternatives.
• Portion-Controlled Packaging: With many weight loss medication users eating smaller portions, snack companies are focusing on creating portion-controlled packaging that caters to consumers looking for smaller, convenient snacks that fit their reduced appetite.
• Marketing Shifts: Snack brands are shifting their marketing efforts to target consumers focused on wellness and healthy living. Instead of promoting indulgence, these companies are highlighting balanced snacking options that complement a healthier lifestyle.
• Collaborations with Health Brands: Some snack manufacturers are forming partnerships with health and wellness brands to reposition their products as part of a balanced diet. These collaborations aim to integrate snacking into weight management programs, emphasizing snacks that align with nutritional goals.

Despite these efforts, many industry experts predict that the rise in weight loss medications will continue to impact traditional snack sales, particularly those products seen as unhealthy or indulgent.

The drop in snack sales appears to be closely linked to the rising popularity of weight loss medications that suppress appetite and reduce cravings. As more individuals adopt these medications to manage their weight, their snacking habits are shifting toward healthier, more intentional choices. Snack food companies are already adapting to this new consumer landscape, but the ongoing trend suggests that the snack industry will need to continue evolving to meet the changing demands of health-conscious consumers.